We predict that 2022 will be another favorable, yet unpredictable, year for the cannabis industry, which is expected to hit $30 billion in sales.

We predict that 2022 will be another favorable, yet unpredictable, year for the cannabis industry, which is expected to hit $30 billion in sales. Creative, nimble and well-capitalized businesses will thrive, while new entrants in established markets may struggle to gain footing amid banking and tax obstacles.

One thing is clear: momentum for federal legalization is building as consumers and the industry demand reform.

Your next CBD products are here, and they’re made from orange peels.

Former NFL player Chris Hetherington has officially introduced the first orange-derived CBD oil, Peels, that promises a more consistent, pure, and stable texture, as well as zero trace of THC compared to regular CBD products extracted from hemp plants to the U.S. through its direct-to-consumer website.

Molecularly Identical To Cannabis CBD

Lately, there’s been quite a bit of ‘buzz’ about the notion of cannabis tourism and its potential impact on global tourism generally.  

I have attended several webinars and information sessions over the past year or two directed at tour operators, restaurateurs, and innkeepers on how to prepare for and engage potential audiences.  

It appears that operating cannabis tourism space will never be easy.  

Even if one thinks they may have the audience part figured out, operating such a business can be difficult to manage, and is dependent upon what region of the world one occupies.  

Light up a joint in some parts of the world and we might never hear from you again… 

Cronos Group (NASDAQ:CRON) has been chomping at the bit to get into the U.S. market. And that's evident even from its financials. Although the company makes the bulk of its money in Canada, it includes that in its "rest of world" segment. The company has been launching hemp-based products in the U.S. for the sake of penetrating the market. And it is also working on developing low-cost cannabis products that could make it a big player in the industry.

Canadian pot producer Cronos Group (CRON) on Monday announced an arrangement to invest in PharmaCann, a large multistate cannabis company in the U.S. Cronos stock and other marijuana stocks fell.

Under the deal, Cronos — whose higher-ups already have connections with PharmaCann — said a subsidiary had purchased an option to acquire around 10.5% of the U.S. company, which runs marijuana production facilities and dispensaries across six states.

Cannabis brings big money to those U.S. states willing to legalize. This is the message marijuana advocates have been preaching for years, and they take every opportunity to praise it as a selling point.

Some of the latest numbers prove that the sale of cannabis products is poised to become one of the largest, tax-generating inebriation markets in the U.S.

When a company reveals a $1.7-billion annual net loss — as Canopy Growth did on Tuesday — then asserts “very high degree of confidence” it will turn a profit in another year, you could be forgiven some doubt.

On the other hand, the Smiths Falls enterprise is capable of delivering surprising story lines. To date these have come in two separate acts.

Elias Theodorou continues to break down barriers.

Last year, he became the first athlete in Canada to secure a Therapeutic Use Exemption (TUE) for the use of medical cannabis in professional sport. He has now replicated that feat south of the border.

Is Now The Time To Invest In Top Cannabis Stocks?

Is this a good time to invest in the top marijuana stocks to watch? With the market in a downtrend leading cannabis stocks have taken a significant hit in the market.  For the past three months, the marijuana sector has made its way back to trading near December 2020 levels. For the most part, the cannabis sector has now been consolidating at its current levels for quite some time.

The results of the 2020 election in the United States touched off a wave of enthusiasm among Canadian cannabis companies looking to cash in on business opportunities south of the border.

With the Democrats retaining their majority in the House of Representatives while picking up control of the Senate and the White House, it appeared to casual observers that full federal legalization could be just around the corner. This is still possible, but it is by no means certain.

Fortunately, there are plenty of opportunities within the legal hemp-derived CBD space for companies looking to expand their presence south of the border.